- Home
- CPAY vs BNTX Comparison
CPAY vs BNTX Comparison
Compare CPAY & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- BNTX
- Stock Information
- Founded
- CPAY 1986
- BNTX 2008
- Country
- CPAY United States
- BNTX Germany
- Employees
- CPAY N/A
- BNTX N/A
- Industry
- CPAY EDP Services
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPAY Technology
- BNTX Health Care
- Exchange
- CPAY Nasdaq
- BNTX Nasdaq
- Market Cap
- CPAY 24.6B
- BNTX 26.4B
- IPO Year
- CPAY 2010
- BNTX 2019
- Fundamental
- Price
- CPAY $324.34
- BNTX $112.71
- Analyst Decision
- CPAY Buy
- BNTX Strong Buy
- Analyst Count
- CPAY 14
- BNTX 18
- Target Price
- CPAY $397.17
- BNTX $141.60
- AVG Volume (30 Days)
- CPAY 468.3K
- BNTX 722.4K
- Earning Date
- CPAY 08-06-2025
- BNTX 08-04-2025
- Dividend Yield
- CPAY N/A
- BNTX N/A
- EPS Growth
- CPAY 6.08
- BNTX N/A
- EPS
- CPAY 14.26
- BNTX N/A
- Revenue
- CPAY $4,045,005,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- CPAY $13.37
- BNTX N/A
- Revenue Next Year
- CPAY $10.56
- BNTX $10.68
- P/E Ratio
- CPAY $22.74
- BNTX N/A
- Revenue Growth
- CPAY 6.68
- BNTX 0.61
- 52 Week Low
- CPAY $265.06
- BNTX $76.53
- 52 Week High
- CPAY $400.81
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CPAY 44.60
- BNTX 63.00
- Support Level
- CPAY $328.12
- BNTX $105.35
- Resistance Level
- CPAY $337.15
- BNTX $114.00
- Average True Range (ATR)
- CPAY 8.00
- BNTX 2.62
- MACD
- CPAY -0.10
- BNTX 0.53
- Stochastic Oscillator
- CPAY 36.75
- BNTX 89.37
About CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.